Home Tools
Log in
Cart

Search Result

Search Results for " cancer cell "

20

Compounds

Cat No. Product Name Synonyms Targets
T22336 Galloflavin Dehydrogenase
Galloflavin inhibits both the A and B isoforms of lactate dehydrogenase with Ki of 5.46 µM and 15.06 µM, respectively. Galloflavin is also a potential anticancer agent.
T9929 Ramucirumab VEGFR
Ramucirumab is a human VEGFR-2 antagonist for the treatment of solid tumors.
T21588 Olomoucine ERK , CDK
Olomoucine is an ATP competitive inhibitor of Cdk2/cyclin A, Cdc2/CyclinB, CDK2/CyclinE, CDK5/p35, and ERK1/p44 MAP kinase with IC50s of 7, 7, 7, 3 and 25 µM, respectively. Olomoucine regulates cell cycle and exhibits an...
T2455 PFK-015 PFK15,PFK 015 Glucokinase , Autophagy
PFK-015 (PFK15) is an effective inhibitor of PFKFB3 (IC50: 110 nM) and inhibits PFKFB3 activity in Y cells (IC50: 20 nM).
T9810 TNIK-IN-5 Wnt/beta-catenin
TNIK-IN-5 is an potent TNIK inhibitor (IC50= 0.05 μM). TNIK-IN-5 potently inhibits Wnt signaling in intact cells. TNIK-IN-5 exhibits excellent in vitro anti-colorectal cancer activity.
T10777 CG347B HDAC
CG347B is a selective inhibitor of HDAC6.
T13818 Phytohemagglutinin PHA-M Apoptosis
Phytohemagglutinin (PHA-M) is a lectin, isolated from the red kidney bean , induces apoptosis via increasing proapoptotic protein Bax and activating caspases-3. Anti-tumor activity
T6812L Cyclo(-RGDfK) TFA Integrin
Cyclo(-RGDfK) is a selective αvβ3 integrin inhibitor(IC50 : 0.94 nM).
T2325 Neratinib HKI-272 EGFR , HER
Neratinib (HKI-272) (HKI-272) is an orally available, irreversible tyrosine kinase inhibitor for HER2 and EGFR (IC50: 59/92 nM), respectively.
T9271 RAD51-IN-1 DNA/RNA Synthesis
Rad51-in-1 is a derivative of B02 and an effective inhibitor of Rad51.
TN1153 Polyporenic acid C Apoptosis , PARP , Caspase , PI3K
Polyporenic acid C shows inhibitory activity against human collagenase.
TN1839 Kumatakenin Jaranol,Kaempferol 3,7-O-dimethyl ether Apoptosis , Anti-infection
Kumatakenin can suppress >80% of the SOS-inducing activity of Trp-P-1 at <0.06 micromol/mL.
T8668 HM03 HSP
HM03 is a potent and selective inhibitor of HSPA5, and has anticancer activity.
T7200 TAK-960 PLK
TAK-960 is an orally bioavailable, selective inhibitor of Plks with IC50 values of 0.8, 16.9, and 50.2 nM for Plk1, Plk2, and Plk3, respectively.
T5808 (-)-Oxypeucedanin hydrate OXYPEUCEDANIN HYDRATE Others
(-)-Oxypeucedanin hydrate is a furanocoumarin. It has a role as a metabolite.
T6812 Cyclo(-RGDfK) Cyclo (-RGDfK) Integrin
Cyclo(-RGDfK) (Cyclo (-RGDfK)) is an effective and specific αvβ3 integrin inhibitor.
T11631 IFSP1 Ferroptosis
iFSP1, a potent, selective, and glutathione-independent ferroptosis suppressor protein 1 (FSP1) (AIFM2) inhibitor with an EC50 of 103 nM, sensitizes diverse human cancer cell lines to ferroptosis inducers like (1S,3R)-RS...
T22260 Aminopurvalanol A CDK
Aminopurvalanol A is a competitive, selective and cell-permeable inhibitor of cyclin-dependent kinase (CDK) that potently inhibits Cyclin A/cdk2, Cyclin B/cdk1, Cyclin E/cdk2, and P35/cdk5 with IC50 of 33 nM, 33 nM, 28 n...
T24557 NSC756093 NSC-756093,NSC 756093 Others
NSC756093 potentially inhibits GBP1:PIM1 interaction. NSC756093 can be used in ovarian cancer studies.
T9014 SKI-178 Apoptosis , S1P Receptor
SKI-178 is a sphingosine kinase 1 (SphK1) inhibitor with IC50 of 0.1-1.8 μM. It induces prolonged mitosis followed by apoptotic cell death through the intrinsic apoptotic cascade. The sustained activation of CDK1 during ...
1 2 3 4 5 ... 79
TargetMol